Bromelain Inhibits SARS-CoV-2 Infection in VeroE6 Cells
Abstract Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The initial interaction between Transmembrane Serine Protease 2 (TMPRSS2) primed SARS-CoV-2 spike (S) protein and host cell receptor angiotensin-converting enzyme 2 (ACE-2) is a pre-requisite step for this novel coronavirus pathogenesis. Here, we expressed a GFP-tagged SARS-CoV-2 S-Ectodomain in Tni insect cells. That contained sialic acid-enriched N- and O-glycans. Surface resonance plasmon (SPR) and Luminex assay showed that the purified S-Ectodomain binding to human ACE-2 and immunoreactivity with COVID-19 positive samples. We demonstrate that bromelain (isolated from pineapple stem and used as a dietary supplement) treatment diminishes the expression of ACE-2 and TMPRSS2 in VeroE6 cells and dramatically lowers the expression of S-Ectodomain. Importantly, bromelain treatment reduced the interaction between S-Ectodomain and VeroE6 cells. Most importantly, bromelain treatment significantly diminished the SARS-CoV-2 infection in VeroE6 cells. Altogether, our results suggest that bromelain or bromelain rich pineapple stem may be used as an antiviral against COVID-19.Highlights <jats:fig id="ufig1" position="float" fig-type="figure" orientation="portrait"><jats:graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="297366v1_ufig1" position="float" orientation="portrait" /></jats:fig><jats:list list-type="bullet">Bromelain inhibits / cleaves the expression of ACE-2 and TMPRSS2Bromelain cleaves / degrades SARS-CoV-2 spike proteinBromelain inhibits S-Ectodomain binding and SARS-CoV-2 infection.
Medienart: |
Preprint |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
bioRxiv.org - (2020) vom: 18. Sept. Zur Gesamtaufnahme - year:2020 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Sagar, Satish [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
doi: |
10.1101/2020.09.16.297366 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
XBI018798829 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | XBI018798829 | ||
003 | DE-627 | ||
005 | 20230429100236.0 | ||
007 | cr uuu---uuuuu | ||
008 | 200924s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1101/2020.09.16.297366 |2 doi | |
035 | |a (DE-627)XBI018798829 | ||
035 | |a (DE-599)biorXiv10.1101/2020.09.16.297366 | ||
035 | |a (biorXiv)10.1101/2020.09.16.297366 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 570 |q DE-84 | |
100 | 1 | |a Sagar, Satish |e verfasserin |4 aut | |
245 | 1 | 0 | |a Bromelain Inhibits SARS-CoV-2 Infection in VeroE6 Cells |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The initial interaction between Transmembrane Serine Protease 2 (TMPRSS2) primed SARS-CoV-2 spike (S) protein and host cell receptor angiotensin-converting enzyme 2 (ACE-2) is a pre-requisite step for this novel coronavirus pathogenesis. Here, we expressed a GFP-tagged SARS-CoV-2 S-Ectodomain in Tni insect cells. That contained sialic acid-enriched N- and O-glycans. Surface resonance plasmon (SPR) and Luminex assay showed that the purified S-Ectodomain binding to human ACE-2 and immunoreactivity with COVID-19 positive samples. We demonstrate that bromelain (isolated from pineapple stem and used as a dietary supplement) treatment diminishes the expression of ACE-2 and TMPRSS2 in VeroE6 cells and dramatically lowers the expression of S-Ectodomain. Importantly, bromelain treatment reduced the interaction between S-Ectodomain and VeroE6 cells. Most importantly, bromelain treatment significantly diminished the SARS-CoV-2 infection in VeroE6 cells. Altogether, our results suggest that bromelain or bromelain rich pineapple stem may be used as an antiviral against COVID-19.Highlights <jats:fig id="ufig1" position="float" fig-type="figure" orientation="portrait"><jats:graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="297366v1_ufig1" position="float" orientation="portrait" /></jats:fig><jats:list list-type="bullet">Bromelain inhibits / cleaves the expression of ACE-2 and TMPRSS2Bromelain cleaves / degrades SARS-CoV-2 spike proteinBromelain inhibits S-Ectodomain binding and SARS-CoV-2 infection | ||
700 | 1 | |a Rathinavel, Ashok Kumar |e verfasserin |4 aut | |
700 | 1 | |a Lutz, William E. |e verfasserin |4 aut | |
700 | 1 | |a Struble, Lucas R. |e verfasserin |4 aut | |
700 | 1 | |a Khurana, Surender |e verfasserin |4 aut | |
700 | 1 | |a Schnaubelt, Andy T |e verfasserin |4 aut | |
700 | 1 | |a Mishra, Nitish Kumar |e verfasserin |4 aut | |
700 | 1 | |a Guda, Chittibabu |e verfasserin |4 aut | |
700 | 1 | |a Broadhurst, Mara J. |e verfasserin |4 aut | |
700 | 1 | |a Reid, St. Patrick M. |e verfasserin |4 aut | |
700 | 1 | |a Bayles, Kenneth W. |e verfasserin |4 aut | |
700 | 1 | |a Borgstahl, Gloria E. O. |e verfasserin |4 aut | |
700 | 1 | |a Radhakrishnan, Prakash |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2020) vom: 18. Sept. |
773 | 1 | 8 | |g year:2020 |g day:18 |g month:09 |
856 | 4 | 0 | |u http://dx.doi.org/10.1101/2020.09.16.297366 |z kostenfrei |3 Volltext |
912 | |a GBV_XBI | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |j 2020 |b 18 |c 09 | ||
953 | |2 045F |a 570 |